ABCB1 and breast cancer: More recently, a study exhibited that lncRNA-GAS5 could alleviate ABCB1-mediated ADM resistance of BC cells by repressing miR-221-3p, which directly targeted Dickopf Wnt signaling pathway inhibitor 2 (DKK2).